WINDTREE THERAPEUTICS

Serial Number 87003094
Registration 5955827
700

Registration Progress

Application Filed
Apr 15, 2016
Under Examination
Nov 29, 2016
Approved for Publication
Oct 4, 2016
Published for Opposition
Oct 4, 2016
Registered
Jan 7, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-07)
Due: Jan 07, 2026 169 days

Trademark Image

WINDTREE THERAPEUTICS

Basic Information

Serial Number
87003094
Registration Number
5955827
Filing Date
April 15, 2016
Registration Date
January 7, 2020
Published for Opposition
October 4, 2016
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2020
Registration
Registered
Classes
005 010 042

Rights Holder

WINDTREE THERAPEUTICS, INC.

03
Address
2600 KELLY ROAD
SUITE 100
WARRINGTON, PA 18976-3622

Ownership History

Discovery Laboratories, Inc.

Original Applicant
03
Warrington, PA

WINDTREE THERAPEUTICS, INC.

New Owner Before Publication #1
03
WARRINGTON, PA

WINDTREE THERAPEUTICS, INC.

Owner at Publication
03
WARRINGTON, PA

WINDTREE THERAPEUTICS, INC.

Original Registrant
03
WARRINGTON, PA

Legal Representation

Attorney
Janet E. Reed

USPTO Deadlines

Next Deadline
169 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-01-07)
Due Date
January 07, 2026
Grace Period Ends
July 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jan 7, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 21, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 21, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 21, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 21, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 21, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 21, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 7, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 3, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 2, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 2, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 27, 2019 IUAF S USE AMENDMENT FILED Loading...
Nov 27, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 29, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 28, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 21, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
May 21, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 14, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 13, 2018 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 8, 2018 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 8, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 30, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 29, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 24, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
May 24, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 6, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 5, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 4, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 28, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 28, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 28, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 28, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 27, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 25, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 25, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 25, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 29, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 4, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 4, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 14, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 30, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 26, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 26, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 26, 2016 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 26, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 26, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 3, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 3, 2016 ALIE A ASSIGNED TO LIE Loading...
Aug 2, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 2, 2016 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for treatment of upper and lower respiratory diseases and disorders; Pharmaceutical preparations, namely, synthetic pulmonary surfactants for treatment of respiratory conditions
First Use Anywhere: Jun 30, 2019
First Use in Commerce: Jun 30, 2019
Class 010
Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmaceutical preparations and substances; Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmaceutical preparations and substances for treatment of various medical conditions; Medical device, namely, an adapter for facilitating entrainment of liquid, powder or aerosolized pharmaceutical preparations and substances; aerosol dispensers for medical use not filled with pharmaceuticals; medical apparatus which uses heat to generate aerosolized pharmaceutical preparations and substances which is then delivered to patients
First Use Anywhere: Sep 12, 2019
First Use in Commerce: Sep 12, 2019
Class 042
Pharmaceutical research, drug discovery, and drug development services; medical and scientific research in the field of pulmonary diseases; research and development of pharmaceutical preparations for the treatment of pulmonary diseases and disorders; research and development of pharmaceutical preparations and substances for treatment of respiratory conditions; research and development of new products in the field of surfactant replacement therapies for respiratory diseases; research and development of pharmaceutical preparations, namely, pulmonary lung surfactants; pharmaceutical research and development in the field of inhaled pharmaceutical products for all human respiratory indications; research and development services in the field of medical apparatus, appliances and instruments for producing and/or delivering aerosolized pharmaceutical preparations; providing scientific information about pharmaceutical products and services; providing scientific information about pharmaceutical products and services via a website and other forms of media
First Use Anywhere: Apr 18, 2016
First Use in Commerce: Apr 18, 2016

Additional Information

Design Mark
The mark consists of an incomplete square with rounded edges which contains a stylized image of a tree with leaves that are not attached to the branches. The square is centered above the term "WINDTREE", and the term "THERAPEUTICS" is centered below the term "WINDTREE". Both terms are depicted in stylized font.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 010 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"